1262533-07-2

Upstream product

• 1262533-06-1 1-(3-bromophenylamino)-7-nitroisoquinoline-4-carbonitrile 

Downstream Products

• 1262533-16-3 N-(1-(3-bromophenylamino)-4-cyanoisoquinolin-7-yl)furan-3-carboxamide 
• 1262533-15-2 N-(1-(3-bromophenylamino)-4-cyanoisoquinolin-7-yl)furan-2-carboxamide 
• 1262533-12-9 N-(1-(3-bromophenylamino)-4-cyanoisoquinolin-7-yl)-3-morpholinopropanamide 
• 1262533-11-8 N-(1-(3-bromophenylamino)-4-cyanoisoquinolin-7-yl)-3-(4-methylpiperazin-1yl)propanamide 
• 1262533-18-5 N-(1-(3-bromophenylamino)-4-cyanoisoquinolin-7-yl)-1H-indol-2-carboxamide 
• 1262533-10-7 N-(1-(3-bromophenylamino)-4-cyanoisoquinolin-7-yl)propionamide 
• 1262533-13-0 ethyl 1-(3-bromophenylamino)-4-cyanoisoquinolin-7-ylcarbamate 
• 1262533-08-3 N-(1-(3-bromophenylamino)-4-cyanoisoquinolin-7-yl)-4-(dimethylamino)butanamide 
• 1262533-14-1 (S)-N-(1-(3-bromophenylamino)-4-cyanoisoquinolin-7-yl)-5-oxopyrrolidine-2-carboxamide 
• 1262533-09-4 (E)-N-(1-(3-bromophenylamino)-4-cyanoisoquinolin-7-yl)-4-(dimethylamino)but-2-enamide 

Relevant academic research and scientific papers

Synthesis and biological evaluation of 7-substituted-1-(3-bromophenylamino) isoquinoline-4-carbonitriles as inhibitors of myosin light chain kinase and epidermal growth factor receptor

Here we present the synthesis and biological activity of a series of 7-substituted-1-(3-bromophenylamino)isoquinoline-4-carbonitriles as inhibitors of myosin light chain kinase (MLCK) and the epidermal growth factor receptor kinase (EGFR). The inhibitory